Victory Capital Management Inc Neuronetics, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.41 - $2.61 $8,804 - $16,296	-6,244 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.28 - $4.5 $2,877 - $10,116	2,248 Added 56.26%	6,244 $12,000
Q4 2019 Feb 06, 2020	SELL	$4.03 - $9.22 $7,713 - $17,647	-1,914 Reduced 32.39%	3,996 $18,000
Q4 2019 Feb 04, 2020	BUY	$4.03 - $9.22 $673 - $1,539	167 Added 2.91%	5,910 $21,000
Q3 2019 Nov 12, 2019	BUY	$8.31 - $13.03 $14,517 - $22,763	1,747 Added 43.72%	5,743 $48,000
Q3 2018 Nov 01, 2018	SELL	$24.32 - $37.54 $24,417 - $37,690	-1,004 Reduced 20.08%	3,996 $128,000
Q2 2018 Aug 02, 2018	BUY	$26.61 - $27.78 $133,050 - $138,900	5,000 New	5,000 $133,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $32.4M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.